Skip to content

Clinical trials

Rhabdomyosarcoma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rhabdomyosarcoma Country / region: Australia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20091
20102
20111
20131
20151
20161
20171
20181
20191
20203
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting7
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
Children's Oncology Group7
Novartis Pharmaceuticals2
Boehringer Ingelheim1
Bristol-Myers Squibb1
Cellectar Biosciences, Inc.1
Eli Lilly and Company1
SWOG Cancer Research Network1
University of Birmingham1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rhabdomyosarcoma23
Sarcoma13
Neuroblastoma10
Glioma8
Medulloblastoma8
Ependymoma7
Osteosarcoma7
Sarcoma, Ewing7
Hepatoblastoma6
Lymphoma, Non-Hodgkin6

Trials

Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.